Sign inGet started

Mitchener Stephen

Insider CIK 1774519 · KPTI SVP, Chief Business Officer · AXLA SVP & Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KPTI Karyopharm Therapeutics In S Sale2023-03-012023-03-026,357$3.03 $19.3K128,313SEC↗
KPTI Karyopharm Therapeutics In A Award2023-02-282023-03-0260,000— $0134,670SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2022-08-312022-09-0130,000— $030,000SEC↗
KPTI Karyopharm Therapeutics In A Award2022-08-312022-09-0120,000— $070,546SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2022-02-282022-03-0259,400— $059,400SEC↗
KPTI Karyopharm Therapeutics In A Award2022-02-282022-03-0247,250— $050,546SEC↗
KPTI Karyopharm Therapeutics In S Sale2021-12-022021-12-03499$6.69 $3.3K3,296SEC↗
KPTI Karyopharm Therapeutics In S Sale2021-06-022021-06-03528$9.29 $4.9K2,472SEC↗
KPTI Karyopharm Therapeutics In M Exercise deriv2021-05-302021-06-011,500— $01,500SEC↗
KPTI Karyopharm Therapeutics In M Exercise2021-05-302021-06-011,500— $03,000SEC↗
AXLA Axcella Health Inc. A Award deriv2019-12-182019-12-2043,000— $043,000SEC↗